课题基金 / 基金详情

项目摘要

项目成果

Patrick J Loll的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The Josephin domain-containing proteins are one of the five major families of deubiquitinating enzymes (DUBs). The founding member of the family is ataxin-3, a polyglutamine protein and the causative agent of the most common inherited ataxia, spinal cerebellar ataxia type 3 (SCA3, also known as Machado-Joseph disease). Ataxin-3's DUB activity resides in the molecule's N-terminal half, the so-called Josephin domain. Ataxin-3 is linked to many cellular processes that are related to maintaining protein homeostasis, including the transport of misfolded proteins to aggresomes and the flux of proteins through the endoplasmic reticulum-associated degradation pathway (ERAD). Ataxin-3 can also suppress the toxicity of expanded repeat polyglutamine domains. All of these functions require DUB activity, establishing the biological significance of the Josephin domain and hinting at a link between Josephin DUB activity and neurodegeneration induced by protein misfolding. Three homologs of ataxin-3 are encoded in the human genome: The ataxin-3-like protein (AT3L), Josephin-1, and Josephin-2. All three possess DUB activity, but differ substantially in catalytic efficiency and specificity. Josephin domain-containing homologs are conserved in most eukaryotes, including plants and protozoans, implying that this domain and the DUB activity it expresses are responsible for valuable biological functions. We propose to analyze the molecular structure and function of the human Josephin domain-containing proteins in order to understand how they recognize and act upon substrates and other interacting proteins. We will use X-ray crystallography to determine structures for different Josephin domains, alone and in complex with ubiquitin substrates; characterize the DUB activities of the four human Josephin domain-containing proteins, assessing how they bind and cleave both small and large ubiquitin substrates; explore their ubiquitin-binding activities; and probe the interactions of ataxin-3 with its cellular binding partners. PUBLIC HEALTH RELEVANCE: The Josephin domain proteins appear to function in quality control pathways in human cells. Understanding how the Josephin proteins function will help reveal how cells protect themselves from the potentially toxic effects of protein misfolding. The insights obtained from this work will inform efforts to design therapies for disorders in which the cell's quality control pathways are disrupted, such as Huntington's disease, Alzheimer's disease, and Parkinson's disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Antibiotic Recognition and Signaling in Vancomycin-Resistant Enterococci (VRE)
  • 批准号:
    10304192
  • 项目类别:
  • 资助金额:
    $38.87万
  • 财政年份:
    2019
  • 负责人:
    Patrick J Loll
  • 依托单位:
Antibiotic Recognition and Signaling in Vancomycin-Resistant Enterococci (VRE)
  • 批准号:
    10520037
  • 项目类别:
  • 资助金额:
    $38.87万
  • 财政年份:
    2019
  • 负责人:
    Patrick J Loll
  • 依托单位:
Antibiotic Recognition and Signaling in Vancomycin-Resistant Enterococci (VRE)
  • 批准号:
    10062476
  • 项目类别:
  • 资助金额:
    $38.87万
  • 财政年份:
    2019
  • 负责人:
    Patrick J Loll
  • 依托单位:
Novel anti-HIV compounds targeting the HIV-1 matrix protein
  • 批准号:
    10196947
  • 项目类别:
  • 资助金额:
    $55.51万
  • 财政年份:
    2018
  • 负责人:
    Patrick J Loll
  • 依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2010
  • 负责人:
    梁胜
  • 依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    26.0万元
  • 批准年份:
    2010
  • 负责人:
    郭亚芬
  • 依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究